Anti-aging Drugs
eBook - ePub

Anti-aging Drugs

From Basic Research to Clinical Practice

Alexander M Vaiserman, Alexander M Vaiserman

Compartir libro
  1. 570 páginas
  2. English
  3. ePUB (apto para móviles)
  4. Disponible en iOS y Android
eBook - ePub

Anti-aging Drugs

From Basic Research to Clinical Practice

Alexander M Vaiserman, Alexander M Vaiserman

Detalles del libro
Vista previa del libro
Índice
Citas

Información del libro

Aging is a natural phenomenon that is peculiar to all living things. However, accumulating findings indicate that senescence could be postponed or prevented by certain approaches. Substantial evidence has emerged supporting the possibility of radical human health and lifespan extension, in particular through pharmacological modulation of aging. A number of natural dietary ingredients and synthetic drugs have been assumed to have geroprotective potential. In the development of anti-aging therapeutics, several cell, insect, and animal models may provide useful starting points prior to human studies.
This book provides an overview of current research aimed to search for life-extendingmedications and describes pharmacological aspects of anti-aging medicine. Readers are introduced to the fascinating historical background of geroprotection in the first chapter. In-depth information on models for investigating geroprotective drugs precedes a section covering anti-aging properties of pharmaceutical compounds, such as calorie restriction mimetics, autophagy inducers, senolytics and mitochondrial antioxidants. Finally, strategies to translate discoveries from aging research into drugs and healthcare policy perspectives on anti-ageing medicine are provided to give a complete picture of the field.
A timely and carefully edited collection of chapters by leading researchers in the field, this book will be a fascinating and useful resource for pharmacologists, gerontologists and any scientifically interested person wishing to know more about the current status of research into anti-aging remedies, challenges and opportunities.

Preguntas frecuentes

¿Cómo cancelo mi suscripción?
Simplemente, dirígete a la sección ajustes de la cuenta y haz clic en «Cancelar suscripción». Así de sencillo. Después de cancelar tu suscripción, esta permanecerá activa el tiempo restante que hayas pagado. Obtén más información aquí.
¿Cómo descargo los libros?
Por el momento, todos nuestros libros ePub adaptables a dispositivos móviles se pueden descargar a través de la aplicación. La mayor parte de nuestros PDF también se puede descargar y ya estamos trabajando para que el resto también sea descargable. Obtén más información aquí.
¿En qué se diferencian los planes de precios?
Ambos planes te permiten acceder por completo a la biblioteca y a todas las funciones de Perlego. Las únicas diferencias son el precio y el período de suscripción: con el plan anual ahorrarás en torno a un 30 % en comparación con 12 meses de un plan mensual.
¿Qué es Perlego?
Somos un servicio de suscripción de libros de texto en línea que te permite acceder a toda una biblioteca en línea por menos de lo que cuesta un libro al mes. Con más de un millón de libros sobre más de 1000 categorías, ¡tenemos todo lo que necesitas! Obtén más información aquí.
¿Perlego ofrece la función de texto a voz?
Busca el símbolo de lectura en voz alta en tu próximo libro para ver si puedes escucharlo. La herramienta de lectura en voz alta lee el texto en voz alta por ti, resaltando el texto a medida que se lee. Puedes pausarla, acelerarla y ralentizarla. Obtén más información aquí.
¿Es Anti-aging Drugs un PDF/ePUB en línea?
Sí, puedes acceder a Anti-aging Drugs de Alexander M Vaiserman, Alexander M Vaiserman en formato PDF o ePUB, así como a otros libros populares de Medicine y Pharmacology. Tenemos más de un millón de libros disponibles en nuestro catálogo para que explores.

Información

Año
2017
ISBN
9781782629856
Edición
1
Categoría
Medicine
Categoría
Pharmacology

Section IV

Mimicking Caloric Restriction

CHAPTER 10
Mimetics of Caloric Restriction
OLEH LUSHCHAKa* AND DMYTRO GOSPODARYOVa
a Department of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, 57 Shevchenko Str., Ivano-Frankivsk, 76018, Ukraine

10.1Introduction

Caloric restriction or calorie restriction (CR) is a relatively old concept, initially based on the data of McCay and colleagues.1 It was found that dietary-restricted rats lived longer than the corresponding controls.1 It was generally accepted for a long time that total amount of calories in consumed food did influence the life span of tested animals.2,3 After a while, life span extension by CR was observed for many model organisms, including fruit flies and nematodes.3 However, it was difficult to draw a distinct line between malnutrition and life span-prolonging CR. The mechanism of life span extension by limitation of ingested food was obscure. Hence, it is not distinguished whether food restriction improves some health parameters or overeating worsens them. In other words, an optimal caloric state was not set. On the one hand, a calorically restricted diet can be optimal for an organism while increasing the amount of food will worsen health and shorten life span.2,4 On the other hand, a “zero” point for amount of food consumed can be located between a supposedly “calorically restricted” diet and a diet promoting over-nutrition. It was found in the 2000s (Figure 10.1) that not only calories but particular nutrients, namely proteins, may play a role in determining life span.3,59 So, isocaloric diets with different amounts of proteins may result in different life spans of model organisms.3,9 At nearly the same time, the life-prolonging effects of resveratrol, a low molecular phenolic compound, were discovered.10 It was first noticed that resveratrol mimics CR.11,12 The molecular mechanisms of resveratrol were found to be mediated by NAD+-dependent histone deacetylases, sirtuins.11,1315 Parallels between the life-extending effect and mimicking physiological and molecular signs of CR were found for many anti-aging drugs, including glitazones16 and rapamycin.17 Simultaneously, a number of compounds that block catabolism of macronutrients or even ingestion were found to provide life span prolongation.18 For instance, acarbose and 2-deoxyglucose, which block glycogen breakdown and glycolysis, respectively, are among these compounds.18 It is suggested that some CR mimetics are not only inhibitors of catabolism but are signaling molecules shamming energy and/or nutrient sensors of cells. Indeed, a way of blockage of nutrient delivery to cells may not matter. The result is always either a lack of energy in the form of adenosine triphosphate (ATP) or deficiency of some building blocks for synthesis of proteins, polysaccharides and lipids. The question about the superiority of energy over plastic material or vice versa is still unresolved. In addition, it is still not clear whether we should take into account the number of calories in the diet, or dietary composition, or macronutrient balance, or even certain dietary components, which when taken away from the diet would provide life span extension. In this review we will try to provide a comprehensive picture for development of the CR concept, the tissue-specific and intracellular consequences of CR, a description of drugs that mimic CR outcomes, and suggest a mechanism explaining why a decrease in either energy or specific nutrients may lead to an increased life expectancy in particular biological species.
image
Figure 10.1Development of CR concept and related findings. Data were obtained from Masoro.19 The figure is modified from Benjamin et al.20 Briefly, the first book on CR collected data on the effects of CR on organismal life span and was published in 1988. Until the mid-1990s, the life-prolonging effects of CR had been proven for main classes of the Animalia kingdom, including humans. Since the mid-1990s, several other concepts have been overlapping with the CR concept (e.g., the hypothesis of methionine restriction). The first compound that prolongs life span by mimicking CR, resveratrol, was discovered in 2003. In each box: in black font: surname(s) of the investigator(s); in blue font: either model organism tested, or experiment mode, or key finding.

10.2Aging and CR

The first evidence on the ability of CR to extend life span came from experiments performed in rats by McCay and colleagues.1 Further studies showed that CR extended the life span by shifting mortality factors, such as diseases and tumors, to older age. Using different protocols, researchers revealed the life span extension by CR in many organisms like yeast, rotifers, spiders, nematodes, flies, fishes and mammals, including non-human primates (Figure 10.1).

10.2.1CR in Yeast: Saccharomyces cerevisiae

Replicative and chronological life spans are described for unicellular yeast. The replicative life span is measured by the amount of formed daughter cells produced by a single cell. Reduction of the glucose concentration from 2% to 0.5% was the first CR intervention in yeast and this extended the replicative life span two-fold. The same study showed the importance of certain genes (SIR2, FOB1, CYT1) for mediating this phenotype. In addition, gene expression profiles of mutants with overexpression of HXK2 and HAP4 showed significant overlap with CR-treated cells. A similar protocol was used in later studies to show the importance of the TOR pathway and transcription factors Msn2 and Msn4 in mediating life span extension by CR. In addition, many genes and factors were identified in yeast as important regulators of life span. The life-extending properties of many drugs, remedies and natural extracts were later discovered using this method.2123
Chronological life span is also described for unicellular organisms such as yeast Saccharomyces cerevisiae. Determination of chronological life span requires a measurement of the number of alive cells able to produce colonies while transferred to fresh media over different time points.24 Cells are quiescent in the G0 phase of the cell cycle but are metabolically active thus having some similarities to those of postmitotic tissues in adult multicellular organisms. Taking into account the similarities of basic biochemical pathways in yeast and other organisms, the model of yeast replicative and chronological life spans can be success...

Índice